Researchers investigated the long-term of safety and efficacy of subcutaneously injected pertuzumab and trastuzumab in patients with HER2-positive early breast cancer.

The study results “indicate that the public has certain reservations about the integration of AI in health care,” the researchers wrote.

HealthDay News — Cannabis use disorder (CUD) is associated with an increased risk for oral cancer, according to a study published in the September issue of Preventive Medicine Reports.

CLL-314 trial compared the efficacy and safety of pirtobrutinib with ibrutinib in adults with CLL/SLL who were treatment-naïve or who were previously treated and were BTK inhibitor-naïve.

Researchers sought to determine whether daratumumab monotherapy could be effective in delaying progression of SMM.

Although this was a negative study, I think the data shown here contribute to our knowledge of IO treatments in urothelial cancer,” said Michiel Van der Heijden, MD, PhD.

At 25 years, the prostate cancer-specific survival rate was 94% among men with screen-detected prostate cancer who chose primary active surveillance – but prostate cancer progression rates are high.

A substantial proportion of cancer in each country can be prevented by implementing resource-stratified cancer prevention and control measures,” said Ahmedin Jemal, DVM, PhD.

A multivariable analysis revealed that patients in the quartile with the highest energy-adjusted ultra-processed food consumption had a 41% higher risk of developing lung cancer than patients in the ...

Researchers investigated the mediating effect of psychological capital in the relationship between treatment adherence and cancer-related fatigue in patients with breast cancer.

Highest estimated 10- and 15-year survival rates seen for low-grade gliomas; lowest rates seen for high-grade gliomas excluding gliomas not otherwise specified.

In addition to a 69.4% CR rate, the team observed good tolerability of the R2-MTX regimen, suggesting its suitability for older or less fit patients.